MBD2
MOLECULAR TARGETmethyl-CpG binding domain protein 2
MBD2 (methyl-CpG binding domain protein 2) is targeted by 15 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting MBD2
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | DEAD-box RNA Helicases | 1.10 | 2 |
| 2 | Thioctic Acid | 1.10 | 2 |
| 3 | Methylene Blue | 1.10 | 2 |
| 4 | Ampicillin Semi-synthetic derivative of penicillin that functions as | 1.10 | 2 |
| 5 | Cefixime | 1.10 | 2 |
| 6 | Ethidium | 1.10 | 2 |
| 7 | Levodopa | 1.10 | 2 |
| 8 | Thioctic Acid | 1.10 | 2 |
| 9 | myricetin-3-O-galactopyranoside [Supplementary Concept] | 0.69 | 1 |
| 10 | Demeclocycline | 0.69 | 1 |
| 11 | Didanosine | 0.69 | 1 |
| 12 | Dinitolmide | 0.69 | 1 |
| 13 | Edaravone | 0.69 | 1 |
| 14 | Ribitol | 0.69 | 1 |
| 15 | Xylitol | 0.69 | 1 |
About MBD2 as a Drug Target
MBD2 (methyl-CpG binding domain protein 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 15 compounds with documented MBD2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
MBD2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.